Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT06784271
Active, not recruiting Not applicable

Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes

NCT06784271 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-12-02
Last updated
2025-01-20

Condition(s) studied

Performance

Investigational drug(s) / intervention(s)

PhenylcapsaicinPlacebo

Phenylcapsaicin: 2.5mg of Phenylcapsaicin

Placebo: Placebo

Study summary

The aim of this study is to investigate the effect of acute phenylcapsaicin intake during a cross-training session on perceived exertion, performance, and recovery in cross-training athletes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age: 18-35 years. * Body mass index: 18.5-30 kg/m2. * Ability to understand the instructions, objectives, and study protocol. * Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months. * Resident on the island of Tenerife. Exclusion Criteria: * History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus. * Any chronic pathology in which the intake of nutritional supplements, especially pungent components, is not recommended. * Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant. * Use of medications that may affect the study results. * Unstable body weight for 3 months prior to the start of the study (\> 4 kg loss or gain in weight). * Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse. * On a special diet or prescribed for other reasons (e.g., celiac disease).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad de la Laguna Santa Cruz de Tenerife Spain

More Universidad de Granada trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06784271 on ClinicalTrials.gov ↗ ← All trials in Spain